204
Participants
Start Date
June 30, 2002
Primary Completion Date
November 30, 2003
Study Completion Date
February 29, 2004
Fampridine-SR
25mg bid (twice daily)
Placebo
Placebo
SUNY Upstate Clinical Trials Office, Syracuse
Helen Hayes Hospital, West Haverstraw
University of Rochester/Strong Memorial Hospital, Rochester
Thomas Jefferson University Hospital, Philadelphia
INOVA Institute of Research and Education, Falls Church
Medical College of Virginia/VCU, Richmond
Charlotte Institute of Rehabilitation, Charlotte
Coastal AHEC, Wilmington
UAB School of Medicine, 190 Spain Rehab Center, Birmingham
Ohio State University, Columbus
Miami Valley Hospital- Rehabilitation Institute of Medicine, Dayton
University of Michigan, Ann Arbor
Rehabilitation Institute of Michigan, Detroit
Wood VA Medical Center, Milwaukee
Minneapolis VA Hospital, Minneapolis
Hines VA Hospital, Hines
St. Louis University, St Louis
University of Missouri, Columbia
VA North Texas Health Care System, Dallas
Southwestern Medical Center at Dallas, Dallas
Craig Hospital, Englewood
Long Beach VA Medical Center, Long Beach
Santa Clara Valley Medical Center, San Jose
University of California, Davis, Sacramento
University of Washington Medical Center, Dept. of Rehabilitation, Seattle
Hospital for Special Care, New Britain
Boston University Medical Center, Boston
Health Sciences Centre, Winnipeg
Chedoke-McMaster Hospital, Hamilton
St. Mary's of the Lake Hospital, Kingston
Lead Sponsor
Acorda Therapeutics
INDUSTRY